Health
CHOP-led Research Study Identifies Key Target in Treatment-Resistant Hemophilia A – PRNewswire
/PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about…
Hemophilia A is the most common inherited bleeding disorder, affecting 1 in 10,000 men worldwide. The condition is the result of a missing coagulation factor known as factor VIII (FVIII), which leads to uncontrolled bleeding episodes, joint disease, and increased risk of death. To control the disease, patients receive infusions of the FVIII protein to replace the missing coagulation factor, but for reasons scientists haven’t fully understood, approximately 30% of patients with severe hemophilia…
-
General23 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General20 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
General9 hours agoProtecting victims of explicit AI content online
-
Business12 hours agoIs this the best ASX ETF to diversify your portfolio with?